TP53 and neuroblastoma: The results suggest that p53 may influence the anti-tumor effects of 248 and 249 in NB, as p53 is mutated in SK-N-Be2(c), which could account for the enhanced anti-tumor effects of the compounds in SK-N-Be2(c) compared to the other NB cell types tested.